A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects
Clinical trial NCT02415439 · COMPLETED
Trial details
- NCT number
- NCT02415439
- Sponsor
- ReveraGen BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-11-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.